Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone.

Literature DB >> 17600296

Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone.

Elizabeth F Shead, Charles S Haworth, Alison M Condliffe, Damian J McKeon, Mike A Scott, Juliet E Compston.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2007 PMID： 17600296 PMCID： PMC2117234 DOI： 10.1136/thx.2006.075887

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

5 in total

1. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.

Authors: S J King; D J Topliss; T Kotsimbos; I B Nyulasi; M Bailey; P R Ebeling; J W Wilson
Journal: Eur Respir J Date: 2005-01 Impact factor: 16.671

2. Osteoclast formation and bone resorption are inhibited by megakaryocytes.

Authors: C A Beeton; S Bord; D Ireland; J E Compston
Journal: Bone Date: 2006-07-25 Impact factor: 4.398

3. Severe osteopenia in CFTR-null mice.

Authors: Fariel Dif; Caroline Marty; Claude Baudoin; Marie-Christine de Vernejoul; Giovanni Levi
Journal: Bone Date: 2004-09 Impact factor: 4.398

4. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.

Authors: Kim Henriksen; Jeppe Gram; Sophie Schaller; Bjarne H Dahl; Morten H Dziegiel; Jens Bollerslev; Morten A Karsdal
Journal: Am J Pathol Date: 2004-05 Impact factor: 4.307

Review 5. Antibodies for CFTR studies.

Authors: Filipa Mendes; Carlos M Farinha; Mónica Roxo-Rosa; Pascale Fanen; Aleksander Edelman; Robert Dormer; Margaret McPherson; Heather Davidson; Edith Puchelle; Hugo De Jonge; Ghanshyam D Heda; Martina Gentzsch; Gergely Lukacs; Deborah Penque; Margarida D Amaral
Journal: J Cyst Fibros Date: 2004-08 Impact factor: 5.482

5 in total

20 in total

1. Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors: D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal: Osteoporos Int Date: 2016-05-11 Impact factor: 4.507

Review 2. Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors: J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal: Osteoporos Int Date: 2015-10-02 Impact factor: 4.507

Review 3. Cystic fibrosis: a clinical view.

Authors: Carlo Castellani; Baroukh M Assael
Journal: Cell Mol Life Sci Date: 2016-10-05 Impact factor: 9.261

4. A role for the cystic fibrosis transmembrane conductance regulator in the nitric oxide-dependent release of Cl^- from acidic organelles in amacrine cells.

Authors: Vijai Krishnan; J Wesley Maddox; Tyler Rodriguez; Evanna Gleason
Journal: J Neurophysiol Date: 2017-08-23 Impact factor: 2.714

5. Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors: Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-06-09 Impact factor: 4.052

6. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Authors: Antonius Bronckers; Lida Kalogeraki; Huub J N Jorna; Martina Wilke; Theodore J Bervoets; Donacian M Lyaruu; Behrouz Zandieh-Doulabi; Pamela Denbesten; Hugo de Jonge
Journal: Bone Date: 2009-12-30 Impact factor: 4.398